Frederik M.
- Country
- Germany
- Department
- Obstetrics and Gynecology
Research Overview
- Evaluation of Safety and Efficacy of Elacestrant in Combination Therapies for Patients with Metastatic Breast Cancer: A Phase 1b/2 Open-Label Umbrella Study
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Evaluation of AZD5335 Monotherapy and Combination Therapy in Patients with Platinum-Resistant Recurrent Ovarian Cancer and Lung Adenocarcinoma
Data & Insights
Has run more than one trial at 428 of 687 partner sites.
Specializations
Gynecologic Oncology
Specializes in novel therapeutic approaches for ovarian cancer, including maintenance treatments and targeted therapies for both newly diagnosed and recurrent cases. Investigates treatments for endometrial cancer and vulvar cancer.
- Advanced epithelial ovarian cancer therapy
- Platinum-resistant ovarian cancer treatment
- Rare gynecological tumor management
Breast Cancer Research
Focuses on innovative treatments for various breast cancer subtypes, particularly HER2-positive, triple-negative, and hormone receptor-positive breast cancers.
- Targeted therapies for metastatic disease
- Neoadjuvant treatment approaches
- Novel therapeutic combinations
Precision Medicine
Implements biomarker-driven treatment strategies and investigates molecular targeted therapies across various gynecologic and breast cancers.
- Immunotherapy combinations
- Targeted molecular treatments
- Personalized medicine approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.